200 related articles for article (PubMed ID: 1501510)
1. Advances in sodium-ion coupled biogenic amine transporters.
Graham D; Langer SZ
Life Sci; 1992; 51(9):631-45. PubMed ID: 1501510
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells.
Gu HH; Ahn J; Caplan MJ; Blakely RD; Levey AI; Rudnick G
J Biol Chem; 1996 Jul; 271(30):18100-6. PubMed ID: 8663573
[TBL] [Abstract][Full Text] [Related]
4. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
Bryan-Lluka LJ; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
[TBL] [Abstract][Full Text] [Related]
5. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
Gu H; Wall SC; Rudnick G
J Biol Chem; 1994 Mar; 269(10):7124-30. PubMed ID: 8125921
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
[TBL] [Abstract][Full Text] [Related]
8. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.
Bauman AL; Apparsundaram S; Ramamoorthy S; Wadzinski BE; Vaughan RA; Blakely RD
J Neurosci; 2000 Oct; 20(20):7571-8. PubMed ID: 11027216
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
10. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.
Rothman RB; Vu N; Partilla JS; Roth BL; Hufeisen SJ; Compton-Toth BA; Birkes J; Young R; Glennon RA
J Pharmacol Exp Ther; 2003 Oct; 307(1):138-45. PubMed ID: 12954796
[TBL] [Abstract][Full Text] [Related]
12. In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters.
Chen NH; Reith ME
Methods Enzymol; 1998; 296():719-30. PubMed ID: 9779485
[No Abstract] [Full Text] [Related]
13. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC
J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403
[TBL] [Abstract][Full Text] [Related]
14. Cell-type-specific expression of catecholamine transporters in the rat brain.
Lorang D; Amara SG; Simerly RB
J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
[TBL] [Abstract][Full Text] [Related]
15. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
16. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 2000; 54():59-119. PubMed ID: 10857386
[TBL] [Abstract][Full Text] [Related]
17. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
18. Efflux studies allow further characterisation of the noradrenaline and 5-hydroxytryptamine transporters in rat lungs.
James KM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):126-33. PubMed ID: 9228199
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.
Demchyshyn LL; Pristupa ZB; Sugamori KS; Barker EL; Blakely RD; Wolfgang WJ; Forte MA; Niznik HB
Proc Natl Acad Sci U S A; 1994 May; 91(11):5158-62. PubMed ID: 8197200
[TBL] [Abstract][Full Text] [Related]
20. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
